Clinical trials are research studies that are carried out to assess the effect of any new drug or device on the human body. They evaluate safety, tolerability and also efficacy of the medical treatment on the human body for the first time. Clinical trials are conducted in observance of strict protocols and guidelines to help gain valuable and actionable data for making informed decisions about a treatment under review. These trials are only initiated after safety in animals (if at all) has been clearly understood. That said, drug safety for humans is not guaranteed even as toxicity in animals has been evaluated. Therefore, clinical trials are typically initiated with a modest dosage of the drug to a small group of volunteers. Additional trials are then initiated following responses from these smaller trials.
A cro clinical is an investigation that involves people. The people who participate in clinical trials are volunteers. They include healthy volunteers, as well as patients who have a disease or condition under study. All clinical trials begin with very small groups of people participating, then gradually expand to include more and more people. Clinical trials are research studies that are carried out to assess the effect of novel drugs or devices on the human body to prevent, cure, or manage various medical conditions. These trials evaluate the safety and efficacy of the medical treatment on the human body for the first time. Clinical trials are conducted in observance of strict protocols and guidelines to help gain valuable and actionable data for making informed decisions about the treatment under review.
Cystatin C is an important kidney biomarker. Researchers first described Cystatin C as a gamma trace found in the urine and cerebrospinal fluid of patients with kidney failure. All nucleated human cells produce cystatin C. CST3 gene encodes cystatin C, which belongs to the gene family of type 2 cystatin. Cystatin C is a kidney biomarker that monitors renal function, predicts cardiovascular disease and protects the body against amyloid plaques. Cystatin C also acts as a biomarker for liver cirrhosis and other disorders that harm the body’s largest organ. Moreover, cystatin c test helps detect kidney disorders like hypertension and prevent diabetes. If you are suffering from one of these conditions or want to know about your kidneys health for any other reason, then book your order right away!
Cystatin C is an important kidney biomarker and has many applications in the detection of kidney disorders, cardiovascular diseases and neurological disorders. When it comes to kidneys, research shows that elevated cystatin c levels correlate with kidney disease. On the other hand, low cystatin c levels are linked to cardiovascular issues such as heart attacks and stroke. Cystatin C is an important kidney biomarker. It is a useful marker for kidney function as it reflects the glomerular filtration rate (GFR) and a general evaluation of how well our organs are working. This test is performed to detect early signs of kidney disorders.
Cystatin C is an important biomarker for the detection of kidney disorders and the progression of chronic kidney disease. It can also be used to predict cardiovascular diseases and association with amyloid plaques in neurological disorders.